Acetic acid 5,7-diacetoxy-2-(3,4-diacetoxy-phenyl)-4-oxo-4H-chromen-3-yl ester

ID: ALA19074

Chembl Id: CHEMBL19074

Cas Number: 1064-06-8

PubChem CID: 14005

Max Phase: Preclinical

Molecular Formula: C25H20O12

Molecular Weight: 512.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: NSC-115919 | Quercetin pentaacetate|1064-06-8|Pentaacetylquercetin|Quercetin acetate|3,3',4',5,7-Pentaacetoxyflavone|NSC-115919|G0B9KJ0VKI|QUERCETINPENTAACETATE|[2-acetyloxy-4-(3,5,7-triacetyloxy-4-oxochromen-2-yl)phenyl] acetate|4H-1-Benzopyran-4-one, 3,5,7-tris(acetyloxy)-2-(3,4-bis(acetyloxy)phenyl)-|FLAVONE, 3,3',4',5,7-PENTAHYDROXY-, PENTAACETATE|NSC 115919|BRN 0380215|3,3',4',5,7-Pentahydroxyflavone pentaacetate|UNII-G0B9KJ0VKI|5-18-05-00510 (Beilstein Handbook Reference)|CHEMBL19074|SCHEMShow More

Canonical SMILES:  CC(=O)Oc1cc(OC(C)=O)c2c(=O)c(OC(C)=O)c(-c3ccc(OC(C)=O)c(OC(C)=O)c3)oc2c1

Standard InChI:  InChI=1S/C25H20O12/c1-11(26)32-17-9-20(35-14(4)29)22-21(10-17)37-24(25(23(22)31)36-15(5)30)16-6-7-18(33-12(2)27)19(8-16)34-13(3)28/h6-10H,1-5H3

Standard InChI Key:  JQUHMSXLZZWRHU-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

Associated Targets(non-human)

Akr7a3 Aflatoxin B1 aldehyde reductase (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde1c Phosphodiesterase 1 (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde2a Phosphodiesterase 2A (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
XDH Xanthine dehydrogenase (2296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania peruviana (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania braziliensis (1091 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.2 (197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Arginase (92 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 512.42Molecular Weight (Monoisotopic): 512.0955AlogP: 3.09#Rotatable Bonds: 6
Polar Surface Area: 161.71Molecular Species: NEUTRALHBA: 12HBD:
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 1.06CX LogD: 1.06
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.35Np Likeness Score: 0.68

References

1. Picq M, Prigent AF, Némoz G, André AC, Pacheco H..  (1982)  Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.,  25  (10): [PMID:6292419] [10.1021/jm00352a019]
2. Kohli E, Raj HG, Kumari R, Rohil V, Kaushik NK, Prasad AK, Parmar VS..  (2002)  Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.,  12  (18): [PMID:12182864] [10.1016/s0960-894x(02)00478-x]
3. Biasutto L, Marotta E, De Marchi U, Zoratti M, Paradisi C..  (2007)  Ester-based precursors to increase the bioavailability of quercetin.,  50  (2): [PMID:17228866] [10.1021/jm060912x]
4. Hayashi T, Sawa K, Kawasaki M, Arisawa M, Shimizu M, Morita N..  (1988)  Inhibition of cow's milk xanthine oxidase by flavonoids.,  51  (2): [PMID:3379415] [10.1021/np50056a030]
5. Edwards JM, Raffauf RF, Le Quesne PW..  (1979)  Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones.,  42  (1): [PMID:469554] [10.1021/np50001a002]
6. Chung MI, Gan KH, Lin CN, Ko FN, Teng CM..  (1993)  Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.,  56  (6): [PMID:8350094] [10.1021/np50096a018]
7. Marín C, Boutaleb-Charki S, Díaz JG, Huertas O, Rosales MJ, Pérez-Cordon G, Guitierrez-Sánchez R, Sánchez-Moreno M..  (2009)  Antileishmaniasis activity of flavonoids from Consolida oliveriana.,  72  (6): [PMID:19489596] [10.1021/np8008122]
8. Carver JA, Duggan PJ, Ecroyd H, Liu Y, Meyer AG, Tranberg CE..  (2010)  Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.,  18  (1): [PMID:19931462] [10.1016/j.bmc.2009.10.063]
9. de Sousa LR, Ramalho SD, Burger MC, Nebo L, Fernandes JB, da Silva MF, Iemma MR, Corrêa CJ, de Souza DH, Lima MI, Vieira PC..  (2014)  Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems.,  77  (2): [PMID:24521209] [10.1021/np400717m]

Source